MASIMO CORP
Clinical trial NCT07223164 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-10-01 → 2025-10-31 3. primary completion date: 2026-10-01 → 2025-10-31 4. enrollment: 120 → 102 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical